The trial came after an initial safety trial in which the potential vaccine was tested on subjects between the ages of 18 and 55. In the follow-up trial the vaccine administered to 40 adults aged 56 to 70 and 71 and older.
Immune response
Elderly people who received two doses of 100 micrograms 28 days apart showed an immune response similar to that of young adults. Moderna is already testing a higher dose in a phase 3 trial. This is the final stage before requesting approval.
Also read
Minister De Jonge: ‘Corona vaccine may be available early 2021’
Subjects rated the side effects, including headache, fatigue, body aches, chills, and injection site pain, mild to moderate. In at least two cases, subjects showed serious side effects.
–
Related posts:
Discovering cases of Coronavirus infection among volunteers in Russian vaccine trials
Don't be afraid, heart failure can be prevented in this way: Okezone Lifestyle
This article discusses the impact of COVID-19 on the spread and occurrence of other infectious disea...
Bad news for instant noodles lovers ... know its danger to heart and kidney health
